We conclude that the anti-invasion therapy by targeting the merging point of all upstream networks, acto-myosin component, can be effective in a well conditioned environment but it may have to be well-designed in order to overcome various adaptation the cancer cell may have to in the heterogeneous conditions [68, 69, 71, 73]. Here, MYH14 is linked to cancer.